Vascular Biogenics Ltd.
News
VBL Therapeutics Announces that S-4 Registration Statement for Proposed Merger with Notable Labs Is Declared Effective by SEC
Globe Newswire Merger with Notable expected to close in mid-October, subject to shareholder approval Special shareholder meeting scheduled for October 12, 2023 MODI IN, Israel and NEW YORK, Sept. 06, 2023...\n more…
StockNews.com Begins Coverage on Vascular Biogenics (NASDAQ:VBLT)
Ticker Report StockNews.com initiated coverage on shares of Vascular Biogenics (NASDAQ:VBLT Free Report) in a research note released on Saturday morning. The brokerage issued a sell rating on the...\n more…
Vascular Biogenics (NASDAQ:VBLT) Coverage Initiated at StockNews.com
Ticker Report Research analysts at StockNews.com started coverage on shares of Vascular Biogenics (NASDAQ:VBLT Get Free Report) in a research report issued on Friday. The brokerage set a sell rating on the biopharmaceutical companys stock. Vascular Biogenics Stock Performance Shares ...\n more…
Vascular Biogenics Ltd. (NASDAQ:VBLT) Sees Significant Decline in Short Interest
Zolmax Vascular Biogenics Ltd. (NASDAQ:VBLT Get Free Report) was the recipient of a large drop in short interest in August. As of August 15th, there was short interest totalling 202,100 shares, a drop of 60.9% from the July 31st total of 517,200 shares. Based on an average trading volume of 1,320,000 ...\n more…
Vascular Biogenics (NASDAQ:VBLT) Coverage Initiated by Analysts at StockNews.com
Zolmax StockNews.com began coverage on shares of Vascular Biogenics (NASDAQ:VBLT Free Report) in a report issued on Friday morning. The firm issued a sell rating on the biopharmaceutical companys stock. Vascular Biogenics Stock Performance Shares of Vascular Biogenics stock opened at $0.24 on Friday. The ...\n more…